Replies to post #286455 on Avid Bioservices Inc (CDMO)

[Protector]

Thomas, not 100% clear. However, it doesn't really matter.

Actually there are about 20 companies out there with such diagnostic tests.

So they are either SPECIFIC for a condition, a certain cancer or they can address a group of related cancers (e.g. say lung squamous and non-squamous,etc).

In the case of PPHM they are at least binary ALL CANCERS (positive or negative). They can tell benign or not. They can tell the advancement.
If it is specific, as North suggested, we will have to do some more D&D or wait until PPH makes a more clear announcement on the subject. I am sure it is in the patent.

Most importantly it is a BLOOD TEST. No needs for biopssies (which patients hate) no need for anal insertions as with intestinal cancers (which are time consuming and not a happy experience, as I was told, for the patient), etc.

But there are OTHERS with blood tests, so the blood test as such is not a breakthrough, but being able to do the EXOSOME analysis on a simple blood test is (no tissue required).

And then there is ONE VERY IMPORTANT thing about PPHM exosome test, I don't know anymore if I have this from a conversation or from a publication on the subject BUT THEY DO NOT NEED CENTRIFUGAL processing.

That makes the test QUICK and CHEAP compared to those who do need it. And that opens the door to SAME DAY RESULTS. Go to a center, have your blood taken, waiting room and go home with results. That is a BIG saving of time & resources for patients and doctors.